12:00 AM
 | 
Apr 08, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Iressa gefitinib regulatory update

The College of American Pathologists (CAP), International Association for the Study of Lung Cancer (IASLC) and the Association for Molecular Pathology (AMP) jointly developed an evidence-based guideline on molecular testing for the selection of lung cancer patients for treatment with EGFR and anaplastic lymphoma kinase (ALK)...

Read the full 229 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >